A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases https://www.medrxiv.org/content/10.1101/2022.12.02.22283042
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.